Bausch & Lomb Incorporated successfully secured the transfer of the typosquatted domain preservison.shop via WIPO UDRP. The respondent registered the domain on November 1, 2025, and immediately deployed a copycat website mimicking the complainant’s official PRESERVISION branding and eye vitamin products. Panelist Brigitte Joppich ordered the domain’s transfer on December 23, 2025, resolving the dispute in just over 50 days from registration.
Case Snapshot
| Case Number | D2025-4699 |
|---|---|
| Complainant | Bausch & Lomb Incorporated |
| Respondent | thebestking mu |
| Disputed Domain | preservison.shop |
| Threat Tactic | Typo Domains |
| Decision Date | 2025-12-23 |
| Panelist | Brigitte Joppich |
| Outcome | Transfer |
| Official Source | https://www.wipo.int/amc/en/domains/search/text.jsp?case=D2025-4699 |
Traffic Diversion and Trust Risks of Typo-Targeted Medical Storefronts
The registration of the typosquatted domain preservison.shop directly targets consumers seeking specialized macular degeneration treatments, a sensitive class of eye vitamins marketed under the PRESERVISION brand since 2001. By omitting the second letter ‘i’ from the registered trademark, the respondent exploited common keyboard errors to intercept and divert legitimate web traffic. This tactic creates an immediate commercial threat by redirecting users who intended to visit the complainant’s authentic online channels to an unauthorized third-party digital storefront. Because the product in question is a medical supplement, the risk of traffic diversion is amplified by the critical nature of the health products being sought.
Beyond simple diversion, the hosting of a copycat website on the disputed domain poses severe risks to brand equity and consumer trust. The respondent utilized the complainant’s official corporate logo, trademarks, and protected marketing collateral to advertise ‘PRESERVISION AREDS 2’ products without authorization. This deliberate corporate impersonation deceives users into believing they are transacting with the trademark owner or an authorized seller. While the administrative record contains no proof of actual counterfeit vitamin sales, active email phishing campaigns, or direct transaction metrics, the mere existence of an unverified storefront mimicking a medical brand damages consumer confidence and threatens the integrity of the brand’s authorized distribution network.
Panel Analysis of Confusing Similarity, Rights, and Bad Faith Registration
Under the first element of the UDRP Policy, Panelist Brigitte Joppich evaluated whether the disputed domain name, preservison.shop, is identical or confusingly similar to Bausch & Lomb Incorporated’s registered PRESERVISION mark. The Complainant established its rights through multiple trademark registrations, including United States Reg. No. 2,696,725 registered on March 11, 2003, for eye vitamins marketed since 2001. The Panel found that the disputed domain name incorporates the core of the trademark with only a minor typographical omission, specifically dropping the second letter ‘i’. This slight misspelling of the PRESERVISION mark is legally insufficient to distinguish the domain from the protected trademark, thereby satisfying the standing requirement of Policy paragraph 4(a)(i).
Regarding the second element, the Panel examined whether the Respondent, thebestking mu, possessed any rights or legitimate interests in the disputed domain. The Complainant presented a prima facie case showing that the Respondent is not commonly known by the name ‘preservison,’ has never been a licensee of Bausch & Lomb, and has never received any authorization to register or use the PRESERVISION mark. The Respondent defaulted, failing to submit any response by the WIPO Center’s December 15, 2025 deadline. Because the Respondent failed to rebut these claims or demonstrate any legitimate noncommercial or fair use, the Panel concluded that the second condition under Policy paragraph 4(a)(ii) was fully met.
The bad faith analysis under Policy paragraph 4(a)(iii) focused heavily on the Respondent’s intentional targeting of Bausch & Lomb’s brand equity. The PRESERVISION brand has been actively promoted since 2001, rendering it highly implausible that the Respondent was unaware of the mark when registering the domain on November 1, 2025. This was confirmed by the Respondent’s immediate deployment of a copycat website displaying the Complainant’s official PRESERVISION logo and advertising its ‘PRESERVISION AREDS 2’ product using copied trademark collateral. Under Policy paragraph 4(b)(iv), using a close typo variant to host a copycat online store constitutes an intentional attempt to attract internet users for commercial gain by creating a likelihood of confusion, satisfying the legal standard for registration and use in bad faith.
Strategy Breakdown: Rapid Enforcement and Compelling Evidentiary Proof
The primary factor in the Complainant’s success was the rapid enforcement timeline executed by Bausch & Lomb Incorporated. By filing the WIPO complaint on November 12, 2025, just 11 days after the registration of preservison.shop on November 1, 2025, the Complainant prevented the copycat platform from establishing a prolonged market presence. This swift action left the Respondent with no credible basis to claim any legitimate rights or interests through prior, uncontested use. For IP professionals, this demonstrates that proactive monitoring and immediate filing after detecting typosquatted domains targeting key products can severely limit a respondent’s potential procedural maneuvers.
Furthermore, the Complainant presented undeniable evidence of bad faith registration and use to secure the transfer. Bausch & Lomb documented that the website at preservison.shop was actively hosting a copycat store that prominently displayed the official PRESERVISION logo and marketed the ‘PRESERVISION AREDS 2’ product using content copied directly from the Complainant’s official web presence. This clear-cut evidence of traffic diversion met the criteria of Policy paragraph 4(b)(iv), proving that the Respondent intentionally sought commercial gain by creating consumer confusion. Providing direct visual proof of trademark appropriation made it straightforward for Panelist Brigitte Joppich to find bad faith and order the transfer, even in the event of a respondent default.
Practical Recommendations
- Establish automated brand monitoring systems designed to flag high-probability typo-squatted domains—specifically focusing on the omission of single letters (such as ‘preservison’ for ‘PRESERVISION’)—across high-risk retail gTLDs like ‘.shop’.
- Develop a rapid-response legal pipeline to prepare and file UDRP complaints quickly, mirroring the 11-day turnaround achieved in this case, to minimize the active lifespan of infringing e-commerce websites.
- Secure comprehensive, time-stamped website archives and source code captures of copycat storefronts immediately upon discovery to document the unauthorized use of brand logos, product names, and copyrighted marketing collateral before the content is altered or taken down.
- Maintain a ready-to-deploy portfolio of trademark registration certificates and brand history documentation to streamline the filing process and establish undisputed priority under the first element of the UDRP.
Frequently Asked Questions (FAQ)
Why was the domain preservison.shop considered confusingly similar to Bausch & Lomb’s trademark?
The WIPO panel found that ‘preservison’ is a close typo variant of the registered PRESERVISION mark, omitting only the letter ‘i’. This minor misspelling was deemed insufficient to distinguish the domain from the famous trademark.
What evidence did the panel cite to demonstrate the respondent’s bad faith?
The panel concluded the respondent acted in bad faith by intentionally creating a copycat website that used Bausch & Lomb’s official logo and marketing content to advertise ‘PRESERVISION AREDS 2’ vitamins, clearly aiming to divert traffic for commercial gain.
Did the respondent have any legitimate rights to the disputed domain name?
No. The panel determined the respondent was never authorized or licensed by Bausch & Lomb to use the mark, nor were they commonly known by the name ‘preservison’, thus establishing a lack of rights or legitimate interests.
How quickly was this case resolved, and what was the outcome?
The case was resolved rapidly; the domain was registered on November 1, 2025, the complaint was filed on November 12, 2025, and the WIPO panelist ordered the transfer of the domain to Bausch & Lomb by December 23, 2025.
Need to recover a look-alike domain?
Your brand can be targeted by subtle misspellings designed to deceive customers. Like the Bausch & Lomb case, we provide actionable UDRP strategies to reclaim domains that mimic your identity. Reach out for a consultation on your brand’s domain footprint.
This case note is for informational purposes only and is not legal advice.
